Table 4.
Willingness to Discuss with Staff AOR (p Value) |
|||
---|---|---|---|
Housing Issues | Drug Use and Treatment | Take-Home Naloxone Training | |
Aboriginal and/or Torres Strait Islander origin 1 | - | - | 4.41 (0.024) |
Heroin used most at the Sydney SIF | - | 3.90 (0.02) 1 | 3.62 (0.054) 2 |
Methamphetamine used most the Sydney SIF | - | 2.27 (0.086) | 3.46 (0.069) |
Buprenorphine used most at the Sydney SIF | 0.068 (0.042) | - | - |
Oxycodone used in past month at the Sydney SIF | 3.25 (0.068) | - | - |
Expressed this issue as the most important | 12.74 (p < 0.001) 3 | 3.18 (0.026) 4 | - |
Currently in unstable accommodation | 5.57 (0.009) | - | - |
Currently in drug treatment | - | 0.43 (0.044) | - |
Ever in drug treatment | - | 0.42 (0.087) | - |
Previously received take-home naloxone training | - | 2.28 (0.057) | - |
Experienced overdose outside of the Sydney SIF | 3.32 (0.072) | - | 5.12 (0.008) |
Experienced overdose for the first time since initial visit | - | - | 0.34 (0.081) |
Number of observations | n = 112 | n = 159 | n = 78 5 |
LR chi2, df, (p) | 38.33, 5, (p < 0.001) | 25.65, 6, (0.003) | 15.47, 5, (0.0085) |
Pseudo R2 | 0.345 | 0.1530 | 0.1431 |
1 Self-report, 2 Database records, 3 Housing, 4 Reducing drug use and/or access to treatment, 5 Only included those who were not trained already. Note: multivariate logistic regression models used with stepwise selection (p < 0.1); Adjusted odds ratios (AOR); Supervised Injecting Facility (SIF); Likelihood ratio (LR); Degrees of freedom (df).